KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Inventory Average: 2018-2025

Historic Inventory Average for Aquestive Therapeutics (AQST) over the last 7 years, with Sep 2025 value amounting to $8.0 million.

  • Aquestive Therapeutics' Inventory Average rose 14.46% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year increase of 14.46%. This contributed to the annual value of $6.4 million for FY2024, which is 2.10% up from last year.
  • According to the latest figures from Q3 2025, Aquestive Therapeutics' Inventory Average is $8.0 million, which was up 4.48% from $7.7 million recorded in Q2 2025.
  • Over the past 5 years, Aquestive Therapeutics' Inventory Average peaked at $8.0 million during Q3 2025, and registered a low of $2.6 million during Q1 2021.
  • In the last 3 years, Aquestive Therapeutics' Inventory Average had a median value of $6.9 million in 2023 and averaged $7.0 million.
  • Its Inventory Average has fluctuated over the past 5 years, first declined by 11.54% in 2021, then spiked by 105.77% in 2022.
  • Aquestive Therapeutics' Inventory Average (Quarterly) stood at $3.5 million in 2021, then spiked by 81.21% to $6.3 million in 2022, then rose by 10.74% to $6.9 million in 2023, then decreased by 5.65% to $6.5 million in 2024, then increased by 14.46% to $8.0 million in 2025.
  • Its Inventory Average stands at $8.0 million for Q3 2025, versus $7.7 million for Q2 2025 and $6.6 million for Q1 2025.